Krystal Biotech, Inc. (KRYS)
268.57
-1.43
(-0.53%)
USD |
NASDAQ |
Apr 15, 16:00
268.57
0.00 (0.00%)
After-Hours: 18:30
Krystal Biotech Research and Development Expense (Annual) : 52.32M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amicus Therapeutics, Inc. | 135.84M |
| Scholar Rock Holding Corp. | 206.78M |
| Alkermes Plc | 318.36M |
| Stoke Therapeutics, Inc. | 136.15M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |